SOURCE: https://www.eventbrite.com/e/bii-webinar-crisis-as-catalyst-tickets-104634815550
Shomit Ghose, Tech investor and Adjunct Professor in Entrepreneurship at UC Berkeley, and a great friend of Nordic Innovation House Silicon Valley will be joining the BioInnovation Institute and share his perspectives.
The scope of the COVID-19 pandemic has brought a new set of requirements to healthcare practice worldwide. Curve-flattening and non-pharmaceutical intervention have now entered the lexicon and reflect healthcare’s broader need to become more scalable and virtualized. Digital technology innovations will not only help to address COVID-19’s short-term needs, but will also catalyze the development of virtualized solutions for a range of healthcare conditions for our post-COVID future. Innovations in non-contact, digitally-driven healthcare will be among the most impactful and longest-lasting legacies of the COVID-19 crisis.
Read more in this White Paper written by Shomit Ghose.
Agenda
1. Introduction to BioInnovation Institute (BII) – Jens Nielsen, Chief Executive Officer, BII2. Crisis as Catalyst – Shomit Ghose, General Partner, ONSET Ventures3. Supporting health tech start-ups at BII – Markus J. Herrgård, Chief Technical Officer, BII
About Shomit Ghose
Shomit Ghose is a Tech investor and Partner at ONSET Ventures and Adjunct Professor in Entrepreneurship at UC Berkeley. Prior to entering venture capital, he was a startup software entrepreneur with a career of operating excellence spanning 19 years. Shomit’s startup roles included three highly successful IPOs as SVP of Operations at Tumbleweed Communications; VP of Worldwide Services at BroadVision; and software engineer at Sun Microsystems. He was also CEO and board member of Truviso, for two years leading to its acquisition by Cisco Systems.
At the age of 15, Shomit was awarded two academic scholarships to the University of California, Berkeley, and graduated with a degree in Computer Science. He serves on the advisory boards of UC Berkeley College of Engineering’s Sutardja Center, Innovation Center Denmark’s ScaleIT program, and the Lundbeck Foundation Clinical Research Fellowship Program.
About BioInnovation Institute
BioInnovation Institute is an international initiative for research-based innovation and entrepreneurship, embracing every phase of a life-science start-up. BII, located in Copenhagen, Denmark, offers start-ups in health tech, bioindustrials and therapeutics state-of-the art lab and office facilities, business acceleration programs, start-up business incubation, commercial support, unique funding opportunities and access to high-level mentoring and international networks. BII is an initiative of the Novo Nordisk Foundation. Read more on www.bioinnovationinstitute.com